InMode (INMD) Net Income towards Common Stockholders (2018 - 2026)
InMode (INMD) posted Net Income towards Common Stockholders of $11.6 million for Q1 2026, down 67.49% sequentially from $35.6 million in Q4 2025, and down 36.48% YoY from $18.2 million in Q1 2025.
InMode (INMD) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
InMode has reported Net Income towards Common Stockholders for 9 years, with the latest figure at $11.6 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 36.48% year-over-year to $11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.7 million (up 28.22% YoY) and the FY2025 annual result came in at $126.8 million, up 20.03% from the prior year.
- Net Income towards Common Stockholders retreated to $11.6 million in Q1 2026 per INMD's latest filing, from $35.6 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $65.2 million in Q4 2023 and troughed at -$18.4 million in Q4 2024.
- A 5-year average of $33.5 million and a median of $35.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders sank 128.16% in 2024, then jumped 293.77% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at $37.7 million in 2022, then jumped by 72.81% to $65.2 million in 2023, then plunged by 128.16% to -$18.4 million in 2024, then surged by 293.77% to $35.6 million in 2025, then plunged by 67.49% to $11.6 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $11.6 million, $35.6 million, and $21.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | InMode | 912.51 Mn | 497.35 Mn | 71.52 Mn | 17.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.56 Mn |
| Dec 31, 2025 | 35.56 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.74 Mn |
| Mar 31, 2025 | 18.20 Mn |
| Dec 31, 2024 | -18.35 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 23.82 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | 65.16 Mn |
| Sep 30, 2023 | 46.52 Mn |
| Jun 30, 2023 | 62.23 Mn |
| Mar 31, 2023 | 40.51 Mn |
| Dec 31, 2022 | 37.71 Mn |
| Sep 30, 2022 | 48.79 Mn |
| Jun 30, 2022 | 44.05 Mn |
| Mar 31, 2022 | 30.98 Mn |
| Dec 31, 2021 | 52.69 Mn |
| Sep 30, 2021 | 44.72 Mn |
| Jun 30, 2021 | 40.93 Mn |